Concepedia

Sylvia Varland

SV

Statistics

Publications

11

Citations

623

H-Index

11

Active since

2017

Affiliations

Haukeland University Hospital(Current)

University of Bergen

Ghent University

VIB-UGent Center for Medical Biotechnology

University of Toronto

Sylvia Varland is an author at Haukeland University Hospital specializing in life sciences, molecular biology, and n-terminal acetylation.

ORCID

Publications per year

2017–2023

11

Publications

11

NAA80 is actin’s N-terminal acetyltransferase and regulates cytoskeleton assembly and cell motility

Adrian Drazic, Henriette Aksnes, Michaël Marie et al. · Proceedings of the National Academy of Sciences · 2018 · 206 citations · Full text

, , +13

Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Hanyin Cheng, Avinash V. Dharmadhikari, Sylvia Varland et al. · The American Journal of Human Genetics · 2018 · 88 citations · Full text

, , +17

Structural determinants and cellular environment define processed actin as the sole substrate of the N-terminal acetyltransferase NAA80

Marianne Goris, Robert S. Magin, Håvard Foyn et al. · Proceedings of the National Academy of Sciences · 2018 · 77 citations · Full text

, , +11

N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity

Sylvia Varland, Rui D. Silva, Ine Kjosås et al. · Nature Communications · 2023 · 75 citations · Full text

, , +17

Mechanisms of Congenital Heart Disease Caused by NAA15 Haploinsufficiency

Tarsha Ward, Warren Tai, Sarah U. Morton et al. · Circulation Research · 2021 · 52 citations · Full text

, , +12

1–5 of 11